News First MHRA/NICE aligned guidance due in June The aligned regulatory pathway for UK drugs regulator MHRA and reimbursement authority NICE gets underway on 1st April.
News GLP-1 drugs linked to pancreatitis, gallbladder problems Users of weight-loss therapies based on GLP-1 agonists have been warned to be aware of a rare complication, pancreatitis, that can be severe.
News JPM: Is the UK's clinical trials sector turning a corner? New data from the UK medicines regulator has shown an increase in clinical trial activity in the country, after years of decline.
News UK teams up with Singapore on healthtech regulation A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
News Wellcome donates £2m to UK's digital mental health drive Wellcome has provided £2m in additional funding to the MHRA and NICE for a project to build the use of digital mental health technologies in the NHS.
Patients Every child deserves safe care from day one Patient safety remains one of the most pressing global health challenges of our time.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
